Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Buy” by Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has been given a consensus recommendation of “Buy” by the six research firms that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and two have issued a strong buy recommendation on the company.

Several research firms have recently weighed in on STVN. Weiss Ratings raised shares of Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 16th. Wolfe Research started coverage on shares of Stevanato Group in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price target on the stock. Finally, TD Cowen upgraded Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th.

Insider Buying and Selling

In related news, CFO Lago Marco Dal sold 4,209 shares of the firm’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of €20.09, for a total transaction of €84,558.81. Following the completion of the sale, the chief financial officer directly owned 81,144 shares of the company’s stock, valued at approximately €1,630,182.96. This trade represents a 4.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Elisabetta Magistretti sold 2,045 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €41,084.05. Following the completion of the sale, the director owned 2,930 shares in the company, valued at approximately €58,863.70. This trade represents a 41.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 14,249 shares of company stock valued at $268,346.

Institutional Investors Weigh In On Stevanato Group

A number of institutional investors have recently made changes to their positions in the stock. Conestoga Capital Advisors LLC lifted its stake in Stevanato Group by 7.6% during the first quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock worth $116,762,000 after purchasing an additional 602,050 shares in the last quarter. Confluence Investment Management LLC acquired a new stake in shares of Stevanato Group in the second quarter valued at $6,062,000. Royal Bank of Canada grew its stake in shares of Stevanato Group by 15.8% in the first quarter. Royal Bank of Canada now owns 421,696 shares of the company’s stock valued at $5,798,000 after buying an additional 57,536 shares in the last quarter. Kornitzer Capital Management Inc. KS purchased a new stake in shares of Stevanato Group in the 1st quarter valued at $1,856,000. Finally, Roubaix Capital LLC raised its holdings in shares of Stevanato Group by 96.6% in the 1st quarter. Roubaix Capital LLC now owns 385,316 shares of the company’s stock valued at $5,298,000 after buying an additional 189,343 shares during the period.

Stevanato Group Trading Up 0.0%

Shares of STVN stock opened at €21.20 on Wednesday. The company’s 50-day moving average price is €19.18 and its 200-day moving average price is €17.13. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21. The stock has a market cap of $6.42 billion, a price-to-earnings ratio of 37.87, a PEG ratio of 1.73 and a beta of 0.77. Stevanato Group has a twelve month low of €12.89 and a twelve month high of €28.00.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Wednesday, August 5th. The company reported €0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The firm had revenue of €302.00 million during the quarter. As a group, equities analysts predict that Stevanato Group will post 0.69 earnings per share for the current year.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.